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history and elevated intraocular pressures. A newly proposed risk factor is decreased cerebrospinal fluid pressure (CSFP). This con-
cept is based on the notion that a pressure differential exists across the lamina cribrosa, which separates the intraocular space from
the subarachnoid fluid space. In this construct, an increased translaminar pressure difference will occur with a relative increase in
elevated intraocular pressure or a reduction in CSFP. This net change in pressure is proposed to act on the tissues within the optic
nerve head, potentially contributing to glaucomatous optic neuropathy. Similarly, patients with ocular hypertension who have ele-
vated CSFPs, would enjoy a relatively protective effect from glaucomatous damage. This review will focus on the current literature
pertaining to the role of CSFP in glaucoma. Additionally, the authors examine the relationship between glaucoma and other known
CSFP-related ophthalmic disorders.
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Glaucoma is a distinct optic neuropathy, which results in a
characteristic nerve damage and a typical pattern of visual
field loss. Intraocular pressure (IOP) is one of the most impor-
tant risk factors. One approach to the classification of glau-
coma is open versus closed angle forms. Closed-angle
variants of glaucoma have elevated IOP that is caused by pri-
mary or secondary pathologies that share anatomic crowding
or closure of the aqueous humor drainage system or angle. In
open-angle forms of glaucoma the drainage angle is open,
but for a variety of reasons the IOP may be elevated or re-
mains in the normal range. Regardless of the type of glau-
coma, intraocular pressure reduction by a medical orsurgical approach has been shown to decrease incidence
and progression of glaucoma.
Why glaucoma occurs with normal tension glaucoma
(NTG) or does not occur in some patients with ocular hyper-
tension (OHT) has been debated for decades. Explanations
for NTG include hypotheses of a ‘‘susceptible optic nerve,’’
intrinsic retinal or ganglion cell pathology, inflammatory
causes, undocumented elevations in IOP, and others. There
is likely an interplay of susceptibility factors that decreases
the threshold for glaucomatous injury in these patients de-
spite seemingly normal intraocular pressures, or alternatively
causes a different type of glaucoma. Vascular or perfusion
abnormalities may be important, perhaps in concert with
pressure fluctuations, neuronal excitotoxicity, genetice:
al.com
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factors.1–3 However, it has been determined that reducing
IOP is beneficial in patients with normal tension glaucoma.
Conversely, a variety of explanations have been offered for
the observation that a relatively small percentage of patients
with documented elevation of IOP out of the normal range
ultimately develop glaucomatous damage. For these reasons
it has become clear that factors in addition to IOP play an
important role in glaucoma pathogenesis.Figure 1. Histologic anatomy of the posterior globe and optic nerve with sur
that acts as a sieve and allows the passage of exiting retinal ganglion cell axo
subarachnoid space between the dura mater and the pia mater investing the
Histology Learning System (Deborah W. Vaughan, PhD).
Figure 2. Spectrum of cerebrospinal fluidRecent studies have implicated the role of pressure of the
primary fluid within the central nervous system, the cerebro-
spinal fluid (CSF), as a major contributor to glaucoma. The
anatomical landmark of interest is the lamina cribrosa, a thin
area of scleral tissue that separates two differentially pressur-
ized compartments – the intraocular space and the orbital
subarachnoid space. (Fig. 1) The difference in pressure be-
tween these two fluid spaces is termed the translaminar pres-
sure. When described as a function of pressure across therounding tissue. The lamina cribrosa (red) is a thin section of scleral tissue
ns and the retinal vessels. The cerebrospinal fluid (blue) flows within the
optic nerve. Modified and reproduced with permission, Boston University
pressure-related ophthalmic disease.
CSFP and Glaucoma 99tissues of the optic nerve and lamina cribrosa the term is
more accurately stated as the translaminar pressure gradient.
It is hypothesized that an elevated posteriorly-directed pres-
sure differential may contribute to optic nerve damage and
produces posterior bowing of the lamina cribrosa, which is
often seen in patients with glaucoma. At the other end of
the spectrum, increased posterior pressure, a pressure vector
in the anterior direction toward the intraocular fluid compart-
ment, associated with elevated intracranial hypertension, can
cause papilledema. (Fig. 2).
We review here the risk factors for glaucoma in the con-
text of this glaucoma–CSFP model. The relevant anatomy is
reviewed, as are plausible mechanisms that could result in
glaucomatous optic neuropathy as well as conditions on the
other end of the CSFP spectrum that are also explained by
this model.Primary open-angle glaucoma, normal tension
glaucoma, ocular hypertension – and the
translaminar pressure difference
The earliest evidence that CSFP may play a role in glau-
coma was reported by Yablonski and colleagues. In the cat
model, CSFP4 was lowered to –4 mm Hg. One eye was then
cannulated to produce a pressure of 0 mm Hg, while the
other eye was unchanged and maintained at a normal pres-
sure. After 3 weeks, the uncannulated eye developed optic
nerve damage consistent with glaucomatous optic neuropa-
thy. The eye that was cannulated and maintained at a low
pressure similar to the CSF pressure did not develop optic
neuropathy. Morgan and colleagues later performed elegant
studies that examined the effect of altering pressure of the
intraocular and subarachnoid spaces on the lamina cribrosa
in a dog model. They reported that varying CSFP was similar
to altering IOP on the lamina cribrosa, and therefore may be
relevant in the pathogenesis of glaucoma.5 A follow-up study
determined that this effect was possibly similar in human do-
nor eyes.6
Berdahl and colleagues reported a large-scale retrospec-
tive study based on electronic records available from the
Mayo Clinic. Medical records were obtained on over 30,000
patients who underwent diagnostic lumbar punctures. Those
with a diagnosis of primary open-angle glaucoma were com-
pared to age-matched patients without glaucoma as con-
trols. Intracranial pressure in POAG patients was lower than
those without glaucoma (9.2 ± 2.9 mmHg versus
13.0 ± 4.2 mmHg respectively, p < 0.0001).7 A second study
examined ocular hypertensive patients, as well as normal ten-
sion glaucoma patients. Compared to age-matched controls,
patients with POAG were again found to have a statistically
lower CSFP compared to controls (9.1 ± 0.77 mmHg versus
11.8 ± 0.71 mmHg, respectively). Patients with NTG had
even lower pressures compared to standard POAG patients
(8.7 ± 1.16 mmHg). Ocular hypertension patients were found
to have higher CSFP compared to the control patients
(12.6 ± 0.85 mmHg versus 10.6 ± 0.81 mmHg, respectively;
p < 0.05).8
Ren et al. examined this in a prospective study conducted
in Chinese subjects. Patients with POAG (N = 43, 29 POAG;
14 NTG) were compared to 71 non-glaucomatous controls.
This study confirmed the finding that patients with high-pres-
sure POAG had lower CSF (11.7 ± 2.7 mmHg) compared tonormal patients (12.9 ± 1.9 mmHg). They also noted that pa-
tients with NTG had lower CSFP compared to either POAG
or non-glaucomatous controls (9.5 ± 2.2 mmHg). Given the
prospective nature of this study, the examiners were able
to calculate the translaminar pressure difference
(CSFP  IOP) and were able to correlate this measurement
to the mean deviation of patient’s visual fields. In this study
larger translaminar pressure differences were positively cor-
related with visual field loss.9 A second study by the same
group examined ocular hypertension patients compared to
normal patients. Similar to the study by Berdahl et al., a sta-
tistically significant difference between CSFP in OHTN and
non-glaucomatous control subjects was found with OHT pa-
tients having significantly higher pressures (16.0 ± 2.5 mmHg
versus 12.9 ± 1.9 mmHg, respectively; p < 0.001).10Risk factors for glaucoma: a different perspective
The studies cited above provide evidence of a relationship
between CSFP and glaucoma, which raises additional ques-
tions about other factors that may be related to CSFP and,
by association, with glaucoma pathogenesis. Therefore, the
effect of factors such as age, sex, and body mass index
(BMI) has been studied to better understand how these
may affect CSFP as a potential risk factor for glaucoma and
other ocular diseases.Age
Among the multiple risk factors for primary open-angle
glaucoma, age is one of the most noteworthy. Numerous
studies in the United States and around the world have iden-
tified age as an independent risk factor.11–19 A recent study
by Fleischman et al. found a relationship between CSF and
age, which may offer an explanation for age as a risk factor
for POAG.20 Electronic medical records of all patients who
had a lumbar puncture performed at the Mayo Clinic in
Rochester, Minnesota during a 13-year period (1996–2009)
were screened. Patients using medications or having medical
diagnoses known to affect CSFP were excluded from analy-
sis. After all entry criteria were met, 12,118 patients were
qualified for investigation. It was found that mean CSFP
was stable from ages 20–49 years. However, mean CSFP pro-
gressively declined after age 49, from 11.5 ± 2.8 mmHg in
the 20–49 age group to 8.4 ± 2.4 mmHg in the over 90 year
age group (p < 0.001), a 27% reduction.
Assuming a stable IOP, this decline in CSFP with age
would result in a significant increase in the translaminar pres-
sure gradient. Morgan’s studies suggest that the mechanical
effect of changes in CSFP plays a significant role on the mor-
phology of the lamina cribrosa.21,22 Assuming that a decrease
in CSFP is equivalent to a similar increase in IOP, we can eval-
uate this effect in reported population studies that have
examined the prevalence and IOP measurements of persons
diagnosed with glaucoma and controls (Fig. 3). For example,
the Baltimore Eye Survey revealed a 4-fold increase in risk in
the development of glaucoma by a change in IOP of
+3 mmHg.11,23 The Beaver Dam Eye Study found that, on
average, there was a 5 mmHg difference in IOP between pa-
tients with glaucoma and those without.13 In Tajimi, Japan,
researchers found that a 4 mmHg rise in IOP increased risk
for POAG in twofold, even within a normal range of
Figure 3. Averaged data of Friedman’s meta-analysis prevalence studies of primary open-angle glaucoma in the United States, with the age-related
decrease in cerebrospinal fluid pressure superimposed. Data shown are from Caucasian patients, which constitute the principal group contained within
the Mayo Clinic population.
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mean reduction of CSFP with advancing age may be an
important risk factor for glaucoma that has not been ac-
counted among populations.Body mass index
Body Mass Index (BMI) is another variable that has been
reported as a risk factor for glaucoma. A positive correlation
between increased BMI and glaucoma, especially in women,
was identified in Newman-Casey and colleagues’ large longi-
tudinal cohort study in a mostly Caucasian population
(86.7%).26 In their study of the relationship between POAG
and components of the metabolic syndrome, an elevated
BMI in women had a 6% increased hazard of developing
OAG. The study revealed no increased risk for glaucoma in
men. The Tajimi Eye Study (Japan) compared 119 patients
with POAG and 2755 controls, and found no statistically sig-
nificant difference between BMI in either group (22.5 vs. 22.9
respectively, p = 0.28).24 On the other hand, Leske’s Barba-
dos Eye Study identified that a decreased BMI was associ-
ated with greater risk for glaucoma in the BarbadosFigure 4. Graph of mean cerebrospinal fluid pressure with body masspopulation of African ancestry.27 Other studies have had sim-
ilar findings to Leske’s, except in NTG patients or based on
sex.28–30
In their prospective study of CSFP and POAG, Ren and
colleagues found a positive correlation between BMI and
CSFP. In this study, the mean age was 45.7 ± 11.3 years,
and the mean BMI was 23.7 ± 2.7. Univariate analysis re-
vealed CSFP was significantly correlated with higher BMI
(r = 0.50; p < 0.001).31 In a retrospective study, Berdahl
et al., reported results from an analysis of electronic medical
records obtained from 4235 patients with measured BMI.
(Fig. 4) Women had a slightly lower BMI (mean 26.0 ± 5.8)
while men had a slightly higher BMI (27.4 ± 4.6). Univariate
regression models identified a positive linear relationship be-
tween BMI and CSFP (r2 = 0.20, p < 0.001). There was a
37.7% increase in BMI from BMI 18 (8.6 ± 2.1 mmHg) to 39
(14.1 ± 2.5 mmHg).20,32,33
Since BMI is positively associated with CSFP the question
arises as to whether higher BMI may be protective for POAG
and the converse, if lower BMI may increase risk for glau-
coma. The studies cited above found that increased BMI ap-
peared to be protective for POAG in female subjects,index between 18 and 39. Bars represent one standard deviation.
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jects. The reason for this discrepancy is unclear. It is possible
other factors, such as some hormonal element, may be
involved.34
Race
Race is a well-documented risk factor for glaucoma. It is of
great interest to determine whether CSFP varies among dif-
ferent populations and whether this may be part of the expla-
nation for differences in prevalence of glaucoma between
various ethnic groups. Unfortunately, there is no study pow-
ered to determine if there is any differential effect of race
on CSFP. Future large-scale studies of various populations
will be necessary to determine the effect, if any, of race on
CSFP.Physiology of CSFP
The translaminar pressure difference is a relatively simplis-
tic term that does not account for what is clearly a complex
relationship between pressure within and surrounding varied
tissue compartments, body position, and other known and
unknown factors. The pressures within the orbital subarach-
noid space, which comprise the retrolaminar pressures, are
likely different than the pressures in the cranial vault and
the remainder of the neuraxis. CSF pressures are directly
responsive to changes in body position as well as diurnal var-
iation. For example, when humans are upright, intracranial
fluid pressure, due to hydrostatic fluid shifts, may drop to
5 mmHg. Why would the pressure measured by a lumbar
puncture have any relevance?
Embryology of the optic nerve, flow of the CSF
The development of the optic vesicle begins at day 22
with an evagination from the wall of the diencephalon, which
creates the optic vesicle. The optic vesicle invaginates and
forms the optic cup and the optic stalk. The cavity of the op-
tic stalk is eventually filled with the axons of the retinal gan-
glion cells as well as the retinal vessels. The optic nerve, of
course, is an extension of the central nervous system, and
as such is invested by the meninges. The optic nerve, as it ex-
its the eye, is enclosed in dural, arachnoid and pial sheaths, as
well as the circulating fluid of the central nervous system, the
cerebrospinal fluid (CSF). The CSF originates in the choroid
plexus within the third, fourth, and inferior horn of the lateral
ventricles, and drains into the arachnoid villi of the cerebral
venous system, as well as through lymphatic channels.35–39
The fluid flows freely throughout the neuraxis within the sub-
arachnoid space, which includes the optic nerve.
Anatomy and physiology
For the glaucoma-CSF model to make sense, it is essential
to understand the anatomy of the optic nerve head. This must
be done in the broader context of the central nervous system
as well as the intraocular space. The anatomical landmark of
interest is the lamina cribrosa, a thin sieve-like perforation of
the posterior sclera through which the axons of the retinal gan-
glion cells exit the eye. It is generally believed that the lamina
cribrosa is the major site of injury for vision loss related to glau-coma.40–43 This is also the site that experiences the pressure
gradient between the intraocular and extraocular spaces.6,44
The difference between these two spaces is termed the trans-
laminar pressure difference. The resulting force imparted by
the difference of the two pressures is dependent on the thick-
ness of the lamina cribrosa. Jonas et al., in a histomorphometric
study of the lamina cribrosa in glaucomatous and non-glauco-
matous eyes noted that the central lamina cribrosa thickness in
a control group was nearly 250 micrometers thicker than the
glaucoma group. These investigators concluded that this in-
crease in the translaminar pressure gradient in these cases
might be important contributors to the glaucomatous patho-
physiological process.Effect of posture on CSFP
The CSFP measured in the supine position is a static mea-
sure of a dynamic process. Lenfeldt found that CSFP mea-
sured by lumbar puncture accurately represents intracranial
pressure in the lateral decubitus position.45 However, the
CSFP in the intracranial vault decreases and even falls to sub-
zero values in a standing position, and then approaches
equivalence in a prone position. Additionally, the dynamics
of the orbital CSF flow may be different than that of the rest
of the neuraxis. While a different pressure may exist within
the orbital CSF compartment, it is nevertheless continuous
with the rest of the spinal column, and there is evidence that
pressure is transmitted to the optic nerve sheath from fluid
changes elsewhere in the contiguous subarachnoid space.46
Although a formulaic relationship between the orbital CSFP
and intracranial pressure has not been elucidated to this
point, the fact that there is pressure transduction between
the neuraxis and the orbital CSFP suggests that these two
compartments should not be considered separately. There-
fore, for the purpose of considering the translaminar pressure
difference, it is more useful to relatively interpret lumbar
puncture data, as opposed to considering the retrolaminar
pressure strictly as the lumbar puncture opening pressure.
Idiopathic intracranial hypertension (IIH) and papilledema
serve as useful examples. In describing IIH, Corbett and Meh-
ta considered an abnormally elevated CSFP to be greater
than 250 mm H2O (or 18.4 mmHg) as measured in the lateral
decubitus position.47 A pressure under 200 mm H2O
(14.7 mmHg) is considered normal however. Therefore, less
than 4 mmHg is clinically significant, even before taking into
account gross overestimates of the retrolaminar pressure in
the upright position, which is the case approximately two-
thirds of a typical day. The measurement of the opening pres-
sure from a lumbar puncture is important, however it is not
possible currently to assess the impact of postural changes
on the biomechanics and physiology of the lamina cribrosa.What contributes to the pressure of the cerebrospinal
fluid?
In most simplistic terms, much like the eye, the CSFP is a
product of production and drainage of fluid. If we look at
the relationship of age and CSFP described above, the
change in pressure may be a product of decreased resistance
to CSF outflow or decreased CSF production with advancing
age. There is no evidence that outflow resistance decreases
with age – on the contrary, studies report CSF flow resistance
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goes aging changes that lead to decreased CSF produc-
tion.49–51 Current evidence suggests that vasopressin, a
hormone that regulates the choroid plexus is responsible
for a reduction in CSF production. Further, vasopressin-
secreting neurons show increased activity with aging.52,53
This is speculative, of course, but these data do support
the role of reduced CSF production rather than increased
drainage as a possible cause of decrease in CSFP with age.
BMI and CSFP
The effect of body mass index on the cerebrospinal fluid
pressure likely involves a biomechanical explanation. BMI is
positively and independently associated with CSFP.31,32 It is
useful to look at the conceptual opposite of glaucoma – idio-
pathic intracranial hypertension. Studies of IIH suggest that
obesity, in particular central obesity, increases intra-abdominal
pressure.54,55 This results in an increase in venous pressure
from compression of the large central veins, and this ultimately
increases intracranial venous pressure with a corresponding in-
crease in intracranial pressure. A similar mechanism may be
responsible for the effect of BMI in general. However, it is likely
that other factors may play a role in this relationship.
Diurnal variation
Diurnal variation of intraocular pressure has been identi-
fied as a normal physiological process,56,57 but also an inde-
pendent risk factor for the progression of glaucoma.58 This is
just one factor in the translaminar pressure gradient, so it is
useful and necessary to understand if changes exist in CSFP
as a product of the circadian rhythm. To date, it is still un-
known to what extent, if any, diurnal variability has an influ-
ence on the spinal fluid pressure. Severs’ group identified a
significant diurnal fluctuation in CSFP in rats, with pressures
nearly 4 mmHg higher during the nighttime compared to
the daytime (p < 0.05).59,60 Conversely, Lin and Liu found
no significant circadian intracranial pressure variation in Spra-
gue–Dawley rats.61 The latter authors conclude that the
translaminar pressure difference is projected to be higher
during the dark period only due to the change in IOP.
A recent study by Samuels and colleagues investigated
central control of the individual elements of the translaminar
pressure difference – CSFP and IOP – in the context of the
circadian rhythm.62 The dorsomedial and perifornical hypo-
thalamic neurons receive input from the suprachiasmic nu-
cleus, the main regulator of the circadian rhythm. These
dorsomedial and perifornical nuclei, in turn, contain many
efferent sympathetic neurons that likely have an important
role in carrying out the characteristic physiological changes.
Microinjections of GABAA receptor antagonists were admin-
istered into the dorsomedial and perifornical hypothalamus
in a rat model demonstrated an asynchronous elevation of
both CSFP and IOP. These data suggest that IOP and CSFP,
and in turn, fluctuation in the translaminar pressure gradient
may be influenced by diurnal variation.
Genetics
Evidence is rapidly mounting on the importance of a ge-
netic basis for glaucoma. In the context of the CSFP–glau-coma model, there is early evidence that genetic loci
associated with risk for POAG may also be involved in CSF
regulation.63,64 In a study by Wiggs et al., researchers found
that a single nucleotide polymorphism (SNP) located on chro-
mosome 8q22 falls in a region that is known to be actively
transcribed by choroid plexus epithelial cells, nonpigmented
ciliary epithelial cells, and iris pigment epithelial cells. It is
intriguing that cells responsible for the production of the
two circulating fluids of the central nervous system, the
respective contributors to the translaminar pressure differ-
ence, have been strongly associated to NTG.Imaging studies
MRI
Mostly stemming from the desire to approximate intracra-
nial pressures in idiopathic intracranial hypertension, neuro-
imaging has been utilized in an attempt to detect elevated
intracranial pressures. The only ways to accurately assess
the spinal fluid pressures to date are through invasive tech-
niques, including lumbar puncture. Since there is some risk
associated with lumbar punctures or other intraventricular
pressure measurements, non-invasive techniques for estimat-
ing cerebrospinal fluid pressures are highly coveted. Mag-
netic resonance imaging (MRI) may be one possibility.
Many studies have advocated the use of MR imaging in the
estimation of either increased or decreased intracranial pres-
sure.65–70
If retrolaminar pressures are indeed important, then the
pressure in the orbital subarachnoid space must be investi-
gated more closely. Therefore, the diameter or changes in
the optic nerve subarachnoid space width could be useful
in assessing relative pressures for the retrolaminar compo-
nent of the translaminar pressure gradient. (Fig. 5) Wang
et al. found that patients with NTG patients have a signifi-
cantly smaller optic nerve subarachnoid space width (ON-
SASW) compared to non-glaucomatous patients.71 These
findings are consistent with the hypothesis that lower CSFP
may play a role in POAG.Ultrasound
Ultrasound, while not able to provide for posterior optic
nerve sheath measurements, can reliably reveal nerve sheath
diameters in the most anterior aspect of the intraorbital
nerve. Again, interest in this field stems from finding a surro-
gate for lumbar puncture in patients with papilledema and
presumed idiopathic intracranial hypertension46,72–74; to date
no studies on glaucoma patients have been performed. This
may be an important imaging modality for studying CSF and
pressure dynamics in the orbital nerve. Based on Wang’s MR
imaging study, even at 3 mm posterior to the globe, there
were significant differences in nerve sheath diameters be-
tween glaucomatous and non-glaucomatous patients.71 This
is within the range that ultrasound could accurately image.
While unable to provide a quantitative estimation of pressure
(no more than MR imaging could provide), a qualitative esti-
mation has significant utility.
Fluid, compartment and pressure dynamics would likely
best be measured with ultrasonography due to its flexibility,
easy use – especially in comparison to MRI. As humans spend
Figure 5. Magnetic resonance imaging studies are being used to determine the width of the subarachnoid space of the orbital portion of the optic
nerve. As an example, (A) a T2-weighted axial turbo spin echo (TSE) image of a 27 year old white female with an opening pressure of 32 cm H2O with
idiopathic intracranial hypertension, and (B) a T2-weighted axial TSE image of an 86 year old Hispanic female with end-stage primary open angle
glaucoma. Although not measured, there is a gross difference in subarachnoid space thickness of the optic nerve between the two patients.
CSFP and Glaucoma 103most of their day in an upright position, intracranial and orbi-
tal nerve pressures fall to subatmospheric pressures.75,76
Even differences in the prone and supine position, due to
hydrostatic effects and gravity, may result in changes in the
orbital CSFP. While it is possible to perform MRI in a variety
of positions, it is far more challenging. Therefore, ultrasound
offers a potentially more available and practical method to
study orbital fluid dynamics in multiple positions.The CSF model in idiopathic intracranial
hypertension and microgravity-induced visual
impairment/intracranial pressure
Idiopathic intracranial hypertension
If glaucoma is a disease that is due in part to decreased
intracranial pressure, it then serves as the conceptual oppo-
site to idiopathic intracranial hypertension (IIH). Idiopathic
intracranial hypertension is a potentially blinding condition
that results in papilledema from increased intracranial pres-
sure. Interestingly, both IIH and glaucoma produce similar vi-
sual field defects. As described above, there are some
anatomical explanations for a transient increase in CSFP.
Clinical studies also implicate medications such as antibiotics,
vitamin A, retinoid analogues, and hormonal contracep-
tives.77–80 In addition, there are multiple case reports of pa-
tients with ocular hypertension who were treated with
pressure-lowering surgery and subsequently developed
papilledema; they were later found to suffer from IIH.81–83
This suggests that intraocular pressure may actually be an-
other element in this disease. This raises an intriguing idea
of increasing the intraocular pressure for the purpose of
treating papilledema.84,85 Much like the findings of Berdahl
and Ren, an elevated cerebrospinal fluid pressure, as found
in ocular hypertension, could potentially be protective for
glaucoma.
An interesting observation of CSFP trends from the Mayo
Clinic database places IIH and glaucoma at opposite ends of
a spectrum. A study performed using the Mayo Clinic medi-
cal record system from 1976 to 1990 identified nine patients
with IIH.86 Although the sample size is small, the highest rateof the disease occurred between ages 15 and 44, and pa-
tients with a BMI over 26 had a 7–8-fold increased risk of
IIH compared to the general population. Generally, patients
with IIH tend to be younger females with an increased body
mass index.87 Glaucoma patients tend to be older and thin-
ner. These pressures are essentially reference ranges per
age and BMI group. It could be imagined that those patients
at the higher end of the reference range, perhaps over two
standard deviations in the age and BMI charts, would have
significantly higher CSF pressures. This, coupled with de-
creased intraocular pressure, could contribute to IIH. An
opposite scenario may exist in glaucoma.Microgravity-induced visual impairment/intracranial
pressure
A newly described clinical condition resulting from pro-
longed space travel may also highlight the importance of
the translaminar pressure difference. Mader et al. reported
that seven astronauts who were in prolonged space missions
returned with visual disturbances and found to have elevated
intracranial pressures and papilledema.88 We have suggested
that papilledema may be due in part to a cephalad fluid shift
of the CSF which would provide a persistent higher-than-
normal retrolaminar pressure.89 This does not explain the ele-
vated CSFP recorded, however. There are likely biomechan-
ical and physiological metrics for baroregulation that are
altered by prolonged microgravitational exposure. For exam-
ple, just as the carotid sinus contains baroreceptors that reg-
ulate blood pressure, perhaps a similar system exists which
regulates cerebrospinal fluid pressures. After months in a
microgravitational environment, the baroreceptors could re-
quire a significant period of time to return to normal. It has
also been suggested that the valveless venous system within
the intracranial space may cause stagnant venous flow in
microgravity causing a decrease in CSF outflow.90 Again, a
safe increase in intraocular pressure may be an option to de-
crease the translaminar pressure gradient and simulating
ocular hypertension.84,85 Finding or developing medications
or devices that could safely and transiently increase intraocu-
lar pressure may be of interest.
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A decreased cerebrospinal fluid pressure may act in a sim-
ilar manner as an increased intraocular pressure by increasing
the translaminar pressure difference. Reduced CSFP may of-
fer a partial explanation for POAG that occurs in the pres-
ence of normal IOP and may be a contributing factor for
most other forms of glaucoma. Our current inability to quan-
tify the retrolaminar pressure gradient limits efforts to ex-
plore this hypothesis. However, if it was possible to account
for IOP, lamina cribrosa thickness, and CSFP a formulaic cal-
culation could be developed that might help predict glau-
coma risk, risk of glaucoma progression, as well as
contribute to our understanding of other CSFP-related ocular
diseases and provide novel therapeutic opportunities.
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